People

Yukitaka Kojima

mitsui-global.com

Yukitaka Kojima is published in Mitsui Global Investment’s current public team. Yukitaka focuses on healthcare AI. His own biography identifies investment work involving Stately Bio, Leash Bio, Ellipsis Health and Rhino FCP, and support for RallyBio, Bionova, Ensem and Neura Health. Previously he managed investments at Mitsui & Co. and worked in corporate insurance, commodity derivatives and private equity. He studied economics at the University of Tokyo and holds the CFA designation.